Hannover, Germany

Louis Villain

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Louis Villain: Innovator in Chromatography Technologies

Introduction

Louis Villain is a prominent inventor based in Hannover, Germany. He has made significant contributions to the field of chromatography, particularly in the development of multimodal adsorption media. With a total of 9 patents to his name, Villain's work has advanced the purification of biomolecules, which is crucial in various scientific and medical applications.

Latest Patents

Among his latest patents, Villain has developed a multimodal adsorption medium with multimodal ligands. This invention relates to a chromatography medium that enhances the purification process of biomolecules. Another notable patent focuses on an adsorption medium that includes polymeric space elements bonded to a chromatography matrix. This medium is designed to improve the efficiency of biomolecule purification through innovative methods of production and application.

Career Highlights

Louis Villain is currently employed at Sartorius Stedim Biotech GmbH, a company known for its cutting-edge biopharmaceutical solutions. His work at Sartorius has allowed him to collaborate with leading experts in the field, further enhancing his contributions to chromatography technologies.

Collaborations

Some of his notable coworkers include Florian Taft and Hans-Heinrich Hörl. Their collaborative efforts have played a significant role in advancing the research and development of innovative chromatography solutions.

Conclusion

Louis Villain's contributions to the field of chromatography through his patents and work at Sartorius Stedim Biotech GmbH highlight his importance as an inventor. His innovations continue to impact the purification of biomolecules, showcasing the vital role of inventors in scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…